Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Effects on quality of life, anti-cancer responses, breast conserving surgery and survival with neoadjuvant docetaxel: a randomised study of sequential weekly versus three-weekly docetaxel following neoadjuvant doxorubicin and cyclophosphamide in women with primary breast cancer

Figure 3

Kaplan-Meier survival curves of (A) disease-free survival and (B) overall survival between age groups at study entry. HR, hazard ratio; CI, confidence interval; (--), women >50 years; (---), women ≤50 years

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us